7 insiders reported 27 Form 4 transactions for PALISADE BIO, INC. (PALI) over the past 18 months (most recent 2026-08-21). Recent activity: Finley John David (CEO, CFO) Sell 88,400 shares, Finley John David (CEO, CFO) Buy 88,400 shares, Baltera Robert Jr. (Director) Buy 20,000 shares, Baltera Robert Jr. (Director) Buy 25,000 shares, Baltera Robert Jr. (Director) Buy 20,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Finley John David | CEO, CFO | Sell | 88,400 | $0 |
| 2026-08-21 | Finley John David | CEO, CFO | Buy | 88,400 | $0 |
| 2026-07-10 | Baltera Robert Jr. | Director | Buy | 20,000 | $39,798 |
| 2026-07-10 | Baltera Robert Jr. | Director | Buy | 25,000 | $48,900 |
| 2026-07-08 | Baltera Robert Jr. | Director | Buy | 20,000 | $41,040 |
| 2026-07-08 | Finley John David | CEO, CFO | Buy | 335,167 | $0 |
| 2026-07-08 | Jones Mitchell Lawrence | Chief Medical Officer | Buy | 131,167 | $0 |
| 2026-07-08 | Baltera Robert Jr. | Director | Buy | 30,000 | $61,044 |
| 2026-07-08 | Finley John David | CEO, CFO | Sell | 146,798 | $303,343 |
| 2026-07-08 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | 51,880 | $106,536 |
| 2026-07-08 | Finley John David | CEO, CFO | Buy | 133 | $93 |
| 2026-07-06 | Baltera Robert Jr. | Director | Buy | 10,000 | $19,800 |
| 2026-07-06 | Baltera Robert Jr. | Director | Buy | 20,000 | $39,600 |
| 2026-06-18 | Baltera Robert Jr. | Director | Buy | 336,904 | $0 |
| 2026-06-12 | Zwick Jordan Michael | Director | Buy | 336,904 | $0 |
| 2026-06-12 | Wei Binxian | Director | Buy | 592,300 | $0 |
| 2026-06-12 | Wei Binxian | Director | Buy | 20,200 | $0 |
| 2026-06-12 | Williams Donald Allen | Director | Buy | 1.5M | $0 |
| 2026-06-12 | Williams Donald Allen | Director | Buy | 60,666 | $0 |
| 2026-06-12 | Chuang Emil | Director | Buy | 592,300 | $0 |
| 2026-06-12 | Chuang Emil | Director | Buy | 20,200 | $0 |
| 2026-02-13 | Jones Mitchell Lawrence | Chief Medical Officer | Buy | 8,000 | $0 |
| 2026-02-13 | Jones Mitchell Lawrence | Chief Medical Officer | Sell | 1,989 | $3,481 |
| 2026-02-13 | Finley John David | CEO, CFO | Buy | 13,333 | $0 |
| 2026-02-13 | Finley John David | CEO, CFO | Sell | 3,896 | $6,818 |
来源：SEC Form 4 申报文件 · 截至 2026-08-21